TapewireFind a company

person · Reporting owner

BYRNES JOHN P

Disclosed activity across 2 companies

Tapewire entity
95466
SEC CIK
0001216802

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AVANOS MEDICAL, INC.AVNS · Entity 28189DirectorJanuary 03, 2024January 04, 2024
TENET HEALTHCARE CORPTHC · Entity 2563DirectorMay 05, 2017May 09, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AVANOS MEDICAL, INC.

Report date January 03, 2024 · Filed January 04, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect49,618 Reported balance After 2024-01-03 transaction · row 1
1 source row

Row 1 · 2024-01-03 · Grant · Acquired 8,378 · Balance 49,618

F1: Represents restricted share units issued to the Reporting Person on January 3, 2024 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted share units issued to the Reporting Person on January 3, 2024 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.

TENET HEALTHCARE CORP

Report date May 05, 2017 · Filed May 09, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect23,889 Reported balance After 2017-05-05 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2017-05-05 · Grant · Acquired 12,864 · Balance 23,889

F1: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2024 Filed Jan 4, 2024 15:10 UTC AVANOS MEDICAL, INC. AVNS · Entity 28189 GrantCommon Stock 8,378 $0.00 $0.00
Disclosure

SEC source: 0001606498-24-000012 · wk-form4_1704398997.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,618

F1 · shares: Represents restricted share units issued to the Reporting Person on January 3, 2024 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 10:00 UTC AVANOS MEDICAL, INC. AVNS · Entity 28189 GrantCommon Stock 7,008 $0.00 $0.00
Disclosure

SEC source: 0001606498-23-000007 · wf-form4_167293080914267.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,240

F1 · shares: Represents restricted share units issued to the Reporting Person on January 3, 2023 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.

Read SEC document
January 03, 2022 Filed Jan 4, 2022 17:30 UTC AVANOS MEDICAL, INC. AVNS · Entity 28189 GrantCommon Stock 5,354 $0.00 $0.00
Disclosure

SEC source: 0001606498-22-000005 · wf-form4_164133538455765.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,232

F1 · shares: Represents restricted share units issued to the reporting person on January 3, 2022 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 10:25 UTC AVANOS MEDICAL, INC. AVNS · Entity 28189 GrantCommon Stock 4,005 $0.00 $0.00
Disclosure

SEC source: 0001606498-21-000005 · wf-form4_160994672634837.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,878

F1 · shares: Represents restricted share units issued to the reporting person on January 4, 2021 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.

Read SEC document
January 02, 2020 Filed Jan 8, 2020 16:22 UTC AVANOS MEDICAL, INC. AVNS · Entity 28189 GrantCommon Stock 5,293 $0.00 $0.00
Disclosure

SEC source: 0001606498-20-000009 · wf-form4_157851853956770.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,873

F1 · shares: Represents restricted share units issued to the reporting person on January 2, 2020 pursuant to the Avanos Medical, Inc. Outside Director's Compensation Plan.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 09:33 UTC AVANOS MEDICAL, INC. AVNS · Entity 28189 GrantCommon Stock 4,248 $0.00 $0.00
Disclosure

SEC source: 0001606498-19-000006 · wf-form4_154661236312155.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,580

F1 · shares: Represents restricted share units issued to the reporting person on January 2, 2019, pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.

Read SEC document
May 03, 2018 Filed May 4, 2018 10:31 UTC AVANOS MEDICAL, INC. HYH · Entity 28189 GrantCommon Stock 384 $0.00 $0.00
Disclosure

SEC source: 0001606498-18-000036 · wf-form4_152544424205031.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,332

F1 · shares: Represents restricted share units issued to the reporting person on May 3, 2018 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan.

Read SEC document
January 02, 2018 Filed Jan 3, 2018 17:06 UTC AVANOS MEDICAL, INC. HYH · Entity 28189 GrantCommon Stock 2,946 $0.00 $0.00
Disclosure

SEC source: 0001606498-18-000007 · wf-form4_151501718469580.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,948

F1 · shares: Represents restricted share units issued to the reporting person on January 2, 2018 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:45 UTC TENET HEALTHCARE CORP THC · Entity 2563 GrantCommon Stock 12,864 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030976 · doc4.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,889

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
January 03, 2017 Filed Jan 5, 2017 10:02 UTC AVANOS MEDICAL, INC. HYH · Entity 28189 GrantCommon Stock 3,749 $0.00 $0.00
Disclosure

SEC source: 0001606036-17-000006 · primary_doc.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,002

F1 · shares: Represents restricted share units issued to the reporting person on January 3, 2017 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan.

Read SEC document
November 25, 2016 Filed Nov 29, 2016 23:11 UTC TENET HEALTHCARE CORP THC · Entity 2563 GrantCommon Stock 11,025 $16.22 $178,825.50
Disclosure

SEC source: 0001209191-16-152360 · doc4.xml · nonDerivative · entry 1

BYRNES JOHN P · CIK 0001216802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,025

F1 · security: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 4,008 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 7,017 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 4,008 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 7,017 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.